Irregular heart rhythm before or after cardiac catheterization linked to risk of deathMay 06, 2009CHICAGO - Certain heart attack patients who experience a rapid, abnormal heart rhythm before or after a coronary artery intervention or stent placement have a significantly higher risk of death within 90 days of the procedure, according to a study in the May 6 issue of JAMA. The incidence and outcomes of sustained ventricular tachycardia or fibrillation (VT/VF; irregular, rapid abnormal contractions of the ventricles) on patients with ST elevation myocardial infarction (STEMI; a certain pattern on an electrocardiogram following a heart attack) undergoing a coronary angioplasty or stent placement (percutaneous coronary intervention - PCI) have not been well understood, according to background information in the article. Rajendra H. Mehta, M.D., M.S., of the Duke Clinical Research Institute, Durham, N.C., and colleagues evaluated the association of VT/VF and its timing with the risk of death at 30 and 90 days in 5,745 patients with STEMI undergoing PCI at 296 hospitals in 17 countries. The patients were categorized into four groups: no VT/VF; VT/VF any time; early VT/VF, before the end of cardiac catheterization; and late VT/VF, after the end of cardiac catheterization. Of the patients in the trial, VT/VF occurred in 5.7 percent. The majority of VT/VF episodes (90 percent) occurred within 48 hours, and 64 percent occurred before the end of catheterization. The rate of death was significantly higher in patients with any VT/VF compared with those without it (90-day death, 23.2 percent vs. 3.6 percent). Clinical outcomes were particularly worse among patients with late VT/VF, although even those with early VT/VF had a significantly higher event rate compared with those without any VT/VF (90-day mortality for early VT/VF, 17.2 percent; and for late VT/VF, 33.3 percent; vs. 3.6 percent for patients with no VT/VF). After adjusting for various factors, the risk of death at 90 days was more than three times higher for patients with any VT/VF; more than two times higher for early VT/VF; and the risk of death at 90 days was about 5.5 times greater for patients with late VT/VF. Among the factors associated with early VT/VF included lower systolic blood pressure, higher body weight and higher heart rate; factors related to late VT/VF included lower systolic blood pressure, higher heart rate and lack of beta-blockers on admission. "Our analysis identified patients who may benefit from closer surveillance in the intensive care or telemetry unit after the [PCI] procedure because of the risk for late VT/VF. In contrast, because of very low risk for late VT/VF in patients with complete reperfusion [restoration of blood flow], our findings suggest that close monitoring for late VT/VF may not be necessary and these patients may be candidates for early discharge. Because currently the majority of patients with STEMI worldwide are routinely monitored for longer than 72 hours, our findings have the potential to decrease resource use without compromising patient safety when a risk-based strategy of monitoring or early discharge is followed. However, this finding also needs confirmation in future studies," the authors write. JAMA and Archives Journals |
|||||||||||||||||||||
| Related Cardiac Catheterization Current Events and Cardiac Catheterization News Articles Calcium scans may be effective screening tool for heart disease A simple, non-invasive test appears to be an effective screening tool for identifying patients with silent heart disease who are at risk for a heart attack or sudden death. Mount Sinai first in nation to ablate atrial fibrillation using new visually-guided balloon catheter Physicians at The Mount Sinai Medical Center in New York became the first in the U.S. to ablate atrial fibrillation using a visually-guided laser balloon catheter. Comprehensive cardiac CT scan may give clearer picture of significant heart disease A team of researchers led by Massachusetts General Hospital (MGH) radiologists has developed a computed-tomography-based protocol that identifies both narrowing of coronary arteries and areas of myocardial ischemia - restricted blood flow to heart muscle tissue - giving a better indication of clinically significant coronary artery disease. Women with chest pain less likely then men to get proper treatment from paramedics Women with chest pain are less likely than male patients to receive recommended, proven therapies while en route to the hospital. Depression after heart disease ups risk of heart failure Patients with heart disease who are subsequently diagnosed with depression are at greater risk for heart failure (HF), a condition in which the heart can't pump enough blood throughout the body, according to a new study published in the April 21, 2009, issue of the Journal of the American College of Cardiology. Radiation Dose Can Be Reduced For "Triple Rule-Out" Coronary CT Angiography Physicians can dramatically reduce the radiation dose delivered to patients undergoing coronary CT angiography in a "triple rule-out" protocol by simply using tube current modulation, according to a study performed at Thomas Jefferson University Hospital in Philadelphia, PA. 1 in 4 Americans lacks timely access to optimal care during time-sensitive medical emergencies Although most Americans live close to some type of emergency room, as many as one in four Americans are more than an hour away from the type of hospital that's most prepared to save their life during a time-sensitive medical emergency. NCRP Report No. 160 on increased average radiation exposure of the US population Scientists at the American Association of Physicists in Medicine (AAPM) are offering additional background information to help the public avoid misinterpreting the findings contained in a report issued today by the National Council on Radiation Protection and Measurements (NCRP), a non-profit body chartered by the U.S. Congress to make recommendations on radiation protection and measurements. Diseased Heart Valve Replaced Through Small Chest Incision When 91-year-old Irvin Lafferty was diagnosed with severe blockage of his heart valve-hardening that is formally known as aortic valve stenosis-open-heart surgery was out of the question. First trial of gene therapy for advanced heart failure shows promising results Phase I results of the first clinical trial of gene therapy for patients with advanced heart failure show the approach to be promising, with improvements in several measures of the condition's severity. More Cardiac Catheterization Current Events and Cardiac Catheterization News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||